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Background: The primordial odontogenic tumor (POT) is a recently described benign entity with histopathological 
and immunohistochemical features suggesting its origin during early odontogenesis. Aim: To integrate the available 
data published on POT into a comprehensive analysis to better define its clinicopathological and molecular features.
Material and Methods: An electronic systematic review was performed up to September 2019 in multiple databases.
Results: A total of 13 publications were included, representing 16 reported cases and 3 molecular studies. The 
mean age of the affected patients was 11.6 years (range 2-19), with a slight predominance in males (56.25%). The 
posterior mandible was the main location (87.5%), with only two cases affecting the posterior maxilla. All cases 
appeared as a radiolucent lesion in close relationship to an unerupted tooth. Recurrences have not been reported 
to date. Microscopically, POT comprises fibromyxoid tissue with variable cellularity surrounded by a cuboidal to 
columnar odontogenic epithelium but without unequivocal dental hard tissue formation. A delicate fibrous capsule 
surrounds (at least partially) the tumor. The epithelial component shows immunohistochemical positivity for am-
elogenin, CK19, and CK14, and variable expression of Glut-1, Galectin-3 and Caveolin-1, Vimentin, p-53, PITX2, 
Bcl-2, Bax and Survivin; the mesenchymal tissue is positive for Vimentin, CD90, p-53, PITX2, Bcl-2, Bax, and 
Survivin, and the subepithelial region exhibits the strong expression of Syndecan-1 and CD34. The Ki-67 index 
is low (<5%). The negative or weak expression of dentinogenesis-associated genes could explain the inhibition of 
dentin and subsequent enamel formation in this neoplasm.
Conclusion: POT is an entity with a well-defined clinicopathological, immunohistochemical and molecular profile 
that must be properly diagnosed and differentiated from other odontogenic lesions and treated consequently.
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Introduction
In 2014, the primordial odontogenic tumor (POT) was 
described for the first time (1), and subsequently this 
entity was included in the World Health Organization 
(WHO) Classification of Head and Neck Tumours in the 
group of benign mixed neoplasms (2). The name was 
coined due to its possible development from the early 
stages of odontogenesis (Fig. 1).
- Study selection
The titles and abstracts of all studies found in the da-
tabase search were independently reviewed by two 
authors; subsequently, the articles that met the inclu-
sion criteria and those lacking information in the title 
or abstract were completely evaluated using the EBLIP 
Critical Appraisal Checklist. The studies selected by 
each author were crossed to ensure that they were prop-
erly chosen, according to the inclusion criteria and the 
checklist (Fig. 2).
Fig. 1: Process of odontogenesis and suggested location of primor-
dial odontogenic tumor (POT) origin according to developmental 
stages: late cap and early bell.
Since its original description in 2014, sixteen cases of 
POT have been reported in the literature, presenting as 
a well-defined radiolucent lesion in close proximity to 
the crown of an unerupted tooth, producing bone ex-
pansion, radicular resorption and tooth displacement of 
variable extent (3-9).
The aim of this systematic review is to collect and inte-
grate the available data published on POT into a com-
prehensive analysis to better define its clinicopathologi-
cal, radiological and molecular features.
Material and Methods 
This study followed the PRISMA (Preferred Report-
ing Items for Systematic Reviews and Meta-analyses) 
guidelines (10).
- Search strategies
An electronic search was performed up to September 
2019, with date restriction since 2014 (first description 
of the POT). The following databases were accessed: 
PubMed/MEDLINE, Cochrane, and SpringerLink. The 
search strategy used in all databases consisted of the 
following keywords: primordial odontogenic tumor.
- Inclusion and exclusion criteria
The inclusion criteria were as follows: 1) cases diag-
nosed as POT with sufficient clinical, microscopic, and 
immunohistochemical information to confirm a definite 
diagnosis based on the WHO histological classification 
of odontogenic tumors (2), including case reports and 
molecular studies, 2) articles in English language, and 
3) articles included in PubMed/MEDLINE, Cochrane, 
and SpringerLink databases.
The exclusion criteria were as follows: 1) case reports 
without sufficient information to confirm a definite di-
agnosis, 2) book chapters, reviews and meta-analyses, 
3) documents in a different language from English, or 
4) articles published before 2014.
Fig. 2: Study selection flowchart, according to PRISMA guidelines.
- Data extraction
All relevant information, such as reference, year of pub-
lication, patient nationality or country of publication, 
number of cases, patient sex and age, tumor location, 
signs and/or symptoms, imaging presentation, treat-
ment, follow-up, immunohistochemical and molecular 
features, were extracted (when available) using a spe-
cific table.
- Analysis
The abovementioned data were analyzed with descrip-
tive statistics. Since POT is a benign tumor with indo-
lent behavior and no recurrences reported to date, it was 
not necessary to perform statistical tests to evaluate the 




The process of searching and screening the articles is 
summarized in Fig. 2. The initial search recorded a total 
of 277 articles; of these, 116 articles were excluded due to 
duplication. Subsequently, two reviewers, independent-
ly, with a substantial concordance indicated by a kappa 
coefficient of k = 0.76, assessed the titles and abstracts, 
resulting in the exclusion of 146 publications. In the 
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commonly found (in 75% and 87.5% of cases, respec-
tively). Most of these cases involved unerupted teeth, 
particularly the third molar (62.5%), followed by the 
second deciduous molar. The size of the lesions ranged 
from 9 to 90 mm; however, most of these anomalies 
were ≥ 30 mm, with a mean of 41 mm (Table 2, Table 3).
evaluation of the 16 remaining papers, 2 were excluded 
because they were reviews and 1 was excluded for not 
meeting the criteria to confirm the diagnosis of POT.
- Description of the selected studies
A total of 13 publications were included, representing 
16 reported cases and 3 molecular studies (Table 1).
The studies and cases originated from nine countries. 
The study of Mosqueda-Taylor et al., 2014 included six 
cases from four different countries (México, Guatema-
la, Brazil and Spain), and additional cases were report-
ed in the U.S.A., Japan, Egypt, India, México, Brazil 
and the Philippines (Table 2).
- Descriptive analysis of the clinical and radiographic 
features
The age of the patients varies in a range of 2-19 years old, 
with a mean of 11.6. Males were slightly more affected 
(56.25%) with a male to female ratio of 9:7. All cases 
occurred in the posterior region of the jaw, mainly in the 
mandible (87.5%). All patients were asymptomatic, with 
most presenting swelling in the affected region, and in 
only two cases, the tumor was discovered as an inci-
dental radiographic finding (4,8). Radiographically, all 
cases were associated with at least one unerupted tooth, 
with the majority presenting as unilocular and well-
defined radiolucencies, and approximately one-third of 
the cases exhibiting biloculated or multiloculated ap-
pearances. Tooth displacement and root resorption were 
No. Reference Type of study
1 Mosqueda-Taylor et al., 
2014 (1)
Case report and immuno-
histochemical analysis
2 Slater et al., 2016 (4) Case report
3 Ando et al., 2017 (3) Case report




5 Mikami et al., 2017 (5) Case report and immuno-
histochemical analysis
6 Mikami et al., 2018 (12) Immunohistochemical and 
next generation sequencing 
analysis




8 Amer et al., 2018 (7) Case report
9 Pardhe et al., 2018 (6) Case report
10 Almazyad et al., 2018 (8) Case report
11 Bomfim et al., 2018 (9) Case report 
12 Teixeira et al., 2019 (14) Case report 
13 Poomsawat et al., 2019 (11) Case report 







































































































































































Table 2: Clinicopathological and radiographic features of primordial odontogenic tumor.
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Abbreviations. M: male, F: female, NED: no evidence of disease, N/A: not available, *: when available, ~: data obtained after the original 
publication,  RL: radiolucent, UL: unilocular, BL: biloculated, ML: multilocular, WD: well-defined, TD: tooth displacement, RR: root resorp-
tion, ^: assessed by imaging,  Ӻ: measure of surgical specimen, ⍚: the size reported correspond to intraoral swelling, which is not representa-
tive, °: treatment indicated by the diagnosis of odontogenic myxoma in the incisional biopsy.
Variable n = 16 / %
Age (years)  
< 10 6 / 37.5
≥ 10 10 / 62.5
Range:  2 – 19  
Mean:  11,7 ± 6,3  
Gender  
Female 7 / 43.8
Male 9 / 56.2
Location  
Posterior mandible 14/ 87.5
Posterior maxilla 2 / 12.5
Size (higher measure in mm) (n=14)
< 30 4 / 28.6%
≥ 30 10 / 71. 4 %
Range:  9 - 90  
Mean:  41 ± 23.9  
Imaging findings  
WD 16 /100
RL, UL 13 / 81.3
RL, ML 3 / 18.7
RL, BL 2 / 14.2
RR 12-75
TD 14 / 87.5
Involved tooth  
      3rd molar 12-75
      1st PM & 2nd DM 3 /18.8
  Developing tooth NS 1 / 6.2
Abbreviations: RL: radiolucent, UL: unilocular, BL: biloculated, ML: 
multilocular, WD: well-defined, RR: root resorption, TD: tooth displace-
ment, PM: permanent molar, DM: deciduous molar, NS: not specified.
Table 2 cont.: Clinicopathological and radiographic features of primordial odontogenic tumor.
Table 3: Summary of clinical data of POT. All cases, except one, were treated with simple exci-
sion/enucleation with extraction of the involved teeth 
and to date, there are no reports of recurrences (follow-
up range: 3 months to 20 years) (Table 2). One case was 
treated with a partial mandibulectomy due to a misdi-
agnosis of odontogenic myxoma in the incisional biopsy 
(11). Macroscopically, POT is a solid, multilobulated 
whitish and glossy mass, without cystic spaces, and this 
tumor is surrounded by a capsule or at least well demar-
cated from the surrounding structures (1,2,9). In some 
cases, the dental follicle can be identified in the surgical 
specimen with a dark reddish color (4,5,9).
The demographic, clinicopathological and radiographic 
features of the 16 POT cases are summarized in Table 2, 
and the descriptive statistics are summarized in Table 3.
- Histopathological features
POT comprises mesenchymal fibromyxoid tissue with 
variable cellularity that in most cases resembles the 
dental papilla, surrounded at the periphery by a cuboi-
dal to columnar epithelium similar to the inner epithe-
lium of the enamel organ. Occasionally, suprabasal stel-
late reticulum-like areas may be observed. The tumor 
is at least partially enclosed by a thin fibrous capsule 
(Fig. 3). A condensation of mesenchymal cells in the 
subepithelial region is also commonly observed (Fig. 
3). Invaginations of the surrounding epithelium can be 
focally present within the mesenchymal component, re-
sulting in ameloblastic fibroma-like islands on tangen-
tial sections.
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This tumor is devoid of dental hard tissues; neverthe-
less, four authors have described the presence of small 
foci of calcifications within the epithelial tissue, specifi-
cally, the stellate reticulum-like areas. However, no evi-
dence of odontoblastic differentiation or the induction 
of dental hard tissue deposition has been described thus 
far. These intraepithelial calcifications are round small 
masses of hard material with a globular or concentric 
appearance (5,8,9,11).
- Immunohistochemical features
The epithelial component shows consistent immuno-
histochemical positivity for CK14, CK19, amelogenin, 
ameloblastin and dentin sialophosphoprotein precur-
sor (DSPP). However, other markers, such as Glut-1, 
Vimentin, MOC-31, Caveolin-1, Galectin-3, PITX2, 
p53, Bax, Bcl-2, Survivin and PTEN, are variably and 
focally expressed. The mesenchymal tissue is strongly 
positive for Vimentin, Syndecan-1, PITX2, Endoglin 
(CD105), CD34, Cyclin D1, Bax, Bcl-2, Survivin and 
p53, while PTEN, CD90 and DSPP were detected with 
moderate positivity. The proliferation index assessed 
by Ki-67 is <5%. The condensed mesenchymal tissue 
adjacent to the epithelium presents the strong expres-
sion of CD34 and Syndecan-1. This tumor is negative 
for BRAF V600E and calretinin by immunohisto-
chemistry.
- Molecular characterization
To date, 151 cancer- and 42 odontogenesis-associated 
genes have been analyzed in POT by next-generation 
sequencing, and no mutations were detected. Neverthe-
less, the expression of the dentinogenesis-associated 
genes Bglap, Ibsp and Nfic was negative or very weak. 
DSPP mRNA is highly expressed in POT (12).
Discussion
Although POT is a recently described and accepted en-
tity (1,2), this systematic review showed that the 16 cas-
es reported to date exhibit a well-defined profile of clin-
icopathologic, radiographic, immunohistochemical and 
molecular features that can be summarized as follows: 
this tumor occurs in the first and second decades of life, 
affecting the posterior region of the jaw, particularly 
the mandible. Radiographically, POT appears as a well-
defined radiolucent unilocular lesion always associated 
with unerupted teeth, such as deciduous or third molars, 
with a mean size of 4.1 cm, showing tooth displacement 
and frequent root resorption (Table 1, Table 2).
Considering that most lesions appear as unilocular 
radiolucencies in close relationship with the crown of 
an unerupted tooth, the main radiographic differen-
tial diagnosis includes a dentigerous cyst and an am-
eloblastic fibroma; however, multilocular lesions with 
tooth displacement and root resorption could mimic 
other odontogenic tumors and cysts, such as amelo-
blastoma, odontogenic myxoma and odontogenic kera-
tocyst (2,4,11). POT is a benign tumor with an indolent 
course, as there are no reported recurrences after con-
servative excision (Table 1).
Macroscopically, POT is a solid, multilobulated whit-
ish and glossy mass with no evidence of cystic changes, 
and this tumor is well demarcated from the surrounding 
structures. Considering these aspects, it is convenient 
to rule out the possibility of ameloblastic fibroma in ex-
cision specimens and of odontogenic myxofibroma in 
incisional biopsies (1,2,9,11).
Microscopically, POT essentially shows mesenchymal 
fibromyxoid tissue resembling in large areas the dental 
papilla, surrounded by a cuboidal to columnar epithe-
lium that resembles the inner epithelium of the enamel 
organ (Fig. 3) (2,4,5). These features differ from their 
main histopathological differential diagnoses: amelo-
blastic fibroma, hyperplastic dental follicle and odonto-
genic myxoma (1,4). In the last case, it is mandatory to 
identify the highly distinctive features of POT to avoid 
the misdiagnosis of odontogenic myxoma, particularly 
in small incisional biopsies and subsequent overtreat-
ment, a situation that has been reported previously (11).
In a representative biopsy or a complete surgical speci-
men of POT, it is possible to exclude an odontogenic 
Fig. 3: Histological features of POT. A: The fibromyxoid mesenchy-
mal tissue is completely surrounded by cuboidal to columnar odonto-
genic epithelium. A subepithelial cellular condensation of the mesen-
chyme is observed; additionally, higher vascularization is observed 
adjacent to this region. B: In this magnified region, the tumor is cov-
ered by an odontogenic epithelium with ameloblastic and cuboidal 
morphology. The subepithelial mesenchymal condensation (arrows) 
is observed next to a prominent vascularized area (hematoxylin and 
eosin staining, zoom of digitalized slide A: 2x, B: 20x).
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myxoma, since this tumor is not surrounded by an 
odontogenic epithelium, and to differentiate it from an 
ameloblastic fibroma, which presents cords and islands 
of odontogenic epithelium within the dental papilla-like 
myxoid stroma (2). Some authors have stated that the 
areas of ameloblastic epithelium of POT are similar 
to those of the lining of unicystic ameloblastoma (4); 
however, POT presents as a tumor mass and not as a 
cystic lesion. Additionally, the differences in the mes-
enchymal component (fibrous tissue for ameloblastoma 
and fibromyxoid for POT) are helpful in confirming the 
diagnosis (Fig. 3) (2,4).
We excluded a recently published POT case report from 
this study because most of the clinicopathological and 
radiographic characteristics did not match the profile of 
the POT, such as its location (anterior), lack of associa-
tion with an unerupted tooth, small size, subepithelial 
odontoblastic differentiation, and dentinoid production 
(13). Consequently, we consider that this case repre-
sents a developing odontoma, which must be included 
as another differential diagnosis of POT, mainly in very 
small lesions in children. In contrast to odontoma, POT 
does not present the production of dental hard tissues or 
odontoblastic differentiation (Table 2) (3,5,7,14).
Initially, the term POT was coined due to the histologic 
resemblance of the tumor with the appearance of the 
epithelial and mesenchymal elements during the early 
stages of tooth development (Fig. 3), when the epithe-
lium is located peripherally, mimicking the relation be-
tween the inner epithelium of the immature enamel or-
gan and the primitive dental papilla, without inductive 
effects over the ectomesenchyme (Fig. 2) but lacking 
the ability to follow a normal evolution toward histo- 
and morphodifferentiation (1,12). Heterogeneity in epi-
thelial differentiation within the same tumor has been 
documented previously by histopathological analysis, 
describing features, such as localized areas of amelo-
blastic differentiation(3,4) and focal stratum intermedi-
um-like structures, as well as some superficial stellate 
reticulum-like areas, which are not necessarily repre-
sentative of the findings of POT (5,9). The histomorpho-
logical variability may reflect the heterogeneity of the 
tumor caused by, for example, slight differences in the 
state of differentiation among the reported cases (5,12).
Although POT is devoid of dental hard tissues, four 
cases showed small foci of calcifications within the epi-
thelial layer (5,8,9,11), which may suggest that alkaline 
phosphatase could play a role in the formation of these 
calcifications, as occurs in the calcifying epithelial 
odontogenic tumor (15,16).
Immunohistochemically, POT has shown a low pro-
liferation index (<5%), which defines this lesion as a 
slow-growing benign tumor in which cell proliferation 
does not seem to be the main mechanism implicated in 
tumoral growth and expansion (17). Nonetheless, one 
study has shown that the condensed subepithelial re-
gion exhibits higher vascularization and positivity for 
Glut-1 and antiapoptotic markers, suggesting a major 
participation of metabolic, antiapoptotic and angiogenic 
events in tumor growth (5,17).
The immunoexpression patterns described in POT cor-
responded to those found in the normal early stages of 
tooth development: the condensed mesenchymal sub-
epithelial area seems to be the most proliferative and 
shows high expression of Syndecan-1 and CD34, which, 
along with the epithelial expression patterns of CK14, 
CK18 and CK19, and focal PITX2, as well as the mesen-
chymal and epithelial staining for vimentin, resembles 
the initial period of tooth formation, suggesting that 
POT origins around the 10th to 20th week of embryonal 
development (cap stage to late bell stage of tooth germ) 
(Fig. 2) (1,5,12,18).
In fact, the epithelial portion of the tumor consistently 
expresses CK14 and CK19, while other markers, such 
as Vimentin, Amelogenin, Glut-1, MOC-31, and Caveo-
lin-1. Galectin-3, PITX2, p53, Bax, Bcl-2, Survivin and 
PTEN, are variably expressed in focal areas, suggest-
ing a dynamic tissue presenting cells in different stages 
of maturation and exhibiting a transition between early 
stages of tooth development to those with ameloblastic 
maturation but without induction of odontoblastic mat-
uration or production of mineralized tissues (5,17,18). 
This immunohistochemical profile supports the denom-
ination of “primordial” for this tumor.
Recently, somatic mutations of cancer-associated genes, 
such as BRAF V600E (19), SMO (20), KRAS (21), 
PTCH1 (22) and CTNNB1 (23,24), have been reported 
in some benign odontogenic tumors and cysts. These 
findings indicate that neoplastic proliferation of some 
odontogenic tumors may be triggered by genetic altera-
tions affecting oncogenic signaling pathways (25). As 
odontogenic tumors are derived from the cells of the 
tooth-forming apparatus and their remnants (2), the 
evaluation of odontogenesis-associated genes is also 
important to elucidate the pathogenesis of POT. The ab-
sence of immunoexpression of the mutant protein BRAF 
V600E confirms that this mutation is not implicated in 
the pathogenesis of POT, excluding it from the category 
of the BRAF mutated ameloblastic tumors (17).
In the study of Mikami et al., [2018], no somatic muta-
tions were detected when 151 cancer- and 42 odontogen-
esis-associated genes were examined, and the mRNA 
expression level of odontogenesis-associated genes in 
POT was determined by next-generation sequencing. 
Nevertheless, the expression of the dentinogenesis-
associated genes Bglap, Ibsp and Nfic was negative or 
very weak, likely due to epigenetic silencing mecha-
nisms, explaining the inhibition of dentin (and conse-
quently, enamel) formation in POT (12).
In tooth germ development, DSPP is immunohisto-
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chemically positive in preameloblasts and preodonto-
blasts (26). Although DSPP is immunoexpressed in the 
epithelium and mesenchyme of POT, and DSPP mRNA 
is also highly expressed, neither odontoblast differen-
tiation nor the induction of dentin formation is morpho-
logically observed (12,18).
In brief, with the data obtained by immunohistochemi-
cal and genetic studies, we can conclude the following: 
POT is a benign, slow-growing odontogenic neoplasm, 
which shows a low proliferation rate and moderate vas-
cularization (17). The epithelial tissue surrounding the 
tumor mass is nonstatic and shows varying degrees 
of maturation, with a transition from an inner enamel 
epithelium morphology to areas of ameloblastic matu-
ration, but without evidence of induction leading to 
mineralized tissue production (5,17). The subepithelial 
area shows the expression of several proteins, suggest-
ing that it is a highly active tumor region (17,18). The 
pathogenesis of the tumor does not appear to be linked 
with any type of known gene mutation; however, there 
is an inhibition of enamel and dentin formation by the 
downregulated expression of genes and proteins associ-
ated with dentinogenesis (12).
In summary, in this systematic review, we showed that 
the 16 cases reported to date exhibit a well-defined pro-
file of clinicopathologic, radiographic, immunohisto-
chemical and molecular features. Despite the indolent 
clinical course of POT, it is crucial to identify its highly 
distinctive presentation to avoid misdiagnosis, mainly 
in small incisional biopsies and subsequent overtreat-
ment.
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